Valuation: Zoetis Inc.

Market Cap 31.36B 27.42B 25.2B 23.49B 44.54B 2,985B 45.21B 301B 118B 1,467B 118B 115B 5,061B P/E 2026 *
11.6x
P/E 2027 * 10.7x
Enterprise Value 38.09B 33.31B 30.61B 28.53B 54.11B 3,627B 54.92B 365B 143B 1,782B 143B 140B 6,148B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.65x
Free-Float
83.58%
Yield 2026 *
2.88%
Yield 2027 * 3.09%
1 day+2.09%
1 week-1.01%
Current month+5.57%
1 month-5.28%
3 months-34.96%
6 months-38.07%
Current year-38.17%
1 week 62.7
Extreme 62.7
67.74
1 month 62.7
Extreme 62.7
71.76
Current year 62.7
Extreme 62.7
114.98
1 year 62.7
Extreme 62.7
137.26
3 years 62.7
Extreme 62.7
185
5 years 62.7
Extreme 62.7
221
10 years 62.7
Extreme 62.7
221
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2020
Director of Finance/CFO 54 01/06/2021
Chief Tech/Sci/R&D Officer 49 01/01/2026
Director TitleAgeSince
Director/Board Member 68 01/07/2012
Director/Board Member 68 01/01/2013
Chairman 73 26/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%-1.01% - - 31.36B
+3.78%+1.75%+70.77%+149.25% 12.49B
+1.56%-4.08%-12.41%+5.09% 3.84B
+0.15%-2.92%-1.63%+34.69% 3.18B
+2.93%+7.60%+52.54%+28.36% 1.98B
+0.50%+2.89%-27.51%+12.64% 1.66B
+3.61%+4.95%+18.79%+141.72% 1.35B
+2.74%+9.39%-20.23%-10.73% 1.05B
-1.39%-2.21%-7.33%-20.18% 941M
+2.29%+5.22%-14.62%-46.94% 940M
Average +1.83%+2.68%+6.48%+32.65% 3.05B
Weighted average by Cap. +2.29%+2.68%+31.80%+79.72%

Financials

2026 *2027 *
Net sales 9.77B 8.54B 7.85B 7.32B 13.88B 930B 14.08B 93.72B 36.64B 457B 36.67B 35.88B 1,577B 10.17B 8.9B 8.18B 7.62B 14.45B 969B 14.67B 97.59B 38.15B 476B 38.18B 37.36B 1,642B
Net income 2.69B 2.36B 2.17B 2.02B 3.83B 257B 3.88B 25.85B 10.1B 126B 10.11B 9.9B 435B 2.92B 2.56B 2.35B 2.19B 4.15B 278B 4.22B 28.05B 10.97B 137B 10.98B 10.74B 472B
Net Debt 6.74B 5.89B 5.41B 5.05B 9.57B 641B 9.71B 64.62B 25.26B 315B 25.28B 24.74B 1,087B 5.82B 5.09B 4.68B 4.36B 8.27B 554B 8.39B 55.84B 21.83B 272B 21.85B 21.38B 939B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
03/07/26 €66.34 +2.09% 612
02/07/26 €64.98 +0.34% 3,104
01/07/26 €64.76 +3.06% 2,566
30/06/26 €62.84 -3.50% 2,997
29/06/26 €65.12 -2.83% 1,595
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
74.80USD
Average target price
118.29USD
Spread / Average Target
+58.15%

Quarterly revenue - Rate of surprise